Last 12 months
Inside the activity.
1 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 15 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Stoffels PaulusVice Chair, Exec Committee
|
Tax withholdingCommon Stock | 15,884 | $131.94 | $2,095,734.96 |
DisclosureSEC source: 0001225208-19-002352 · doc4.xml · nonDerivative · entry 5 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,516.2242 F5 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Stoffels PaulusVice Chair, Exec Committee
|
GrantCommon Stock | 5,154 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002352 · doc4.xml · nonDerivative · entry 4 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,400.2242 F4 · shares: Shares earned due to performance factor of 116.4% upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Stoffels PaulusVice Chair, Exec Committee
|
Exercise / conversionCommon Stock | 31,428 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002352 · doc4.xml · nonDerivative · entry 3 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,246.2242 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
GrantRestricted Share Units · Derivative | 3,297 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002353 · doc4.xml · derivative · entry 9 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,297 Underlying: Common Stock · 3,297 shares Expires not disclosed F7 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F7 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
Exercise / conversionPerformance Share Units · Derivative | 9,748 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002353 · doc4.xml · derivative · entry 8 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,748 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. F3 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 67,397 | $0.00 Strike: $131.94 | $0.00 |
DisclosureSEC source: 0001225208-19-002353 · doc4.xml · derivative · entry 7 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,397 Underlying: Common Stock · 67,397 shares Expires 2029-02-11 F6 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
Tax withholdingCommon Stock | 6,236 | $131.94 | $822,777.84 |
DisclosureSEC source: 0001225208-19-002353 · doc4.xml · nonDerivative · entry 5 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,751.371 F5 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
GrantCommon Stock | 1,599 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002353 · doc4.xml · nonDerivative · entry 4 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,987.371 F4 · shares: Shares earned due to performance factor of 116.4% upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
Exercise / conversionCommon Stock | 9,748 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002353 · doc4.xml · nonDerivative · entry 3 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,388.371 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Ullmann Michael HExec VP, General Counsel
|
GrantRestricted Share Units · Derivative | 2,407 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002354 · doc4.xml · derivative · entry 13 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,407 Underlying: Common Stock · 2,407 shares Expires not disclosed F10 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F10 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Ullmann Michael HExec VP, General Counsel
|
Exercise / conversionPerformance Share Units · Derivative | 13,273 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002354 · doc4.xml · derivative · entry 12 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,273 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. F4 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Ullmann Michael HExec VP, General Counsel
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 49,200 | $0.00 Strike: $131.94 | $0.00 |
DisclosureSEC source: 0001225208-19-002354 · doc4.xml · derivative · entry 11 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,200 Underlying: Common Stock · 49,200 shares Expires 2029-02-11 F9 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Ullmann Michael HExec VP, General Counsel
|
Tax withholdingCommon Stock | 8,151 | $131.94 | $1,075,442.94 |
DisclosureSEC source: 0001225208-19-002354 · doc4.xml · nonDerivative · entry 7 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,459.882 F6 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Ullmann Michael HExec VP, General Counsel
|
GrantCommon Stock | 2,177 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002354 · doc4.xml · nonDerivative · entry 6 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,610.882 F5 · shares: Shares earned due to performance factor of 116.4% upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Ullmann Michael HExec VP, General Counsel
|
Exercise / conversionCommon Stock | 13,273 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002354 · doc4.xml · nonDerivative · entry 5 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,433.882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
GrantRestricted Share Units · Derivative | 1,896 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002355 · doc4.xml · derivative · entry 11 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,896 Underlying: Common Stock · 1,896 shares Expires not disclosed F9 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F9 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
Exercise / conversionPerformance Share Units · Derivative | 6,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002355 · doc4.xml · derivative · entry 10 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,722 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. F3 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 38,753 | $0.00 Strike: $131.94 | $0.00 |
DisclosureSEC source: 0001225208-19-002355 · doc4.xml · derivative · entry 9 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,753 Underlying: Common Stock · 38,753 shares Expires 2029-02-11 F8 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
Tax withholdingCommon Stock | 4,047 | $131.94 | $533,961.18 |
DisclosureSEC source: 0001225208-19-002355 · doc4.xml · nonDerivative · entry 5 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,600.7975 F5 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
GrantCommon Stock | 1,102 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002355 · doc4.xml · nonDerivative · entry 4 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,647.7975 F4 · shares: Shares earned due to performance factor of 116.4% upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
Exercise / conversionCommon Stock | 6,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002355 · doc4.xml · nonDerivative · entry 3 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,545.7975 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
GrantRestricted Share Units · Derivative | 2,036 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002356 · doc4.xml · derivative · entry 9 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,036 Underlying: Common Stock · 2,036 shares Expires not disclosed F7 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F7 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
Exercise / conversionPerformance Share Units · Derivative | 12,609 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002356 · doc4.xml · derivative · entry 8 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,609 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. F3 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 41,618 | $0.00 Strike: $131.94 | $0.00 |
DisclosureSEC source: 0001225208-19-002356 · doc4.xml · derivative · entry 7 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,618 Underlying: Common Stock · 41,618 shares Expires 2029-02-11 F6 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
Tax withholdingCommon Stock | 7,687 | $131.94 | $1,014,222.78 |
DisclosureSEC source: 0001225208-19-002356 · doc4.xml · nonDerivative · entry 5 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,328.0055 F5 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
GrantCommon Stock | 2,068 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002356 · doc4.xml · nonDerivative · entry 4 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,015.0055 F4 · shares: Shares earned due to performance factor of 116.4% upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
Exercise / conversionCommon Stock | 12,609 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002356 · doc4.xml · nonDerivative · entry 3 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,947.0055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Wolk Joseph JExec VP, CFO
|
GrantRestricted Share Units · Derivative | 3,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002357 · doc4.xml · derivative · entry 10 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,248 Underlying: Common Stock · 3,248 shares Expires not disclosed F8 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F8 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionPerformance Share Units · Derivative | 2,903 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002357 · doc4.xml · derivative · entry 9 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,903 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. F3 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Wolk Joseph JExec VP, CFO
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 66,386 | $0.00 Strike: $131.94 | $0.00 |
DisclosureSEC source: 0001225208-19-002357 · doc4.xml · derivative · entry 8 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,386 Underlying: Common Stock · 66,386 shares Expires 2029-02-12 F7 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Wolk Joseph JExec VP, CFO
|
Tax withholdingCommon Stock | 961 | $131.94 | $126,794.34 |
DisclosureSEC source: 0001225208-19-002357 · doc4.xml · nonDerivative · entry 5 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,920.224 F5 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Wolk Joseph JExec VP, CFO
|
GrantCommon Stock | 476 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002357 · doc4.xml · nonDerivative · entry 4 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,881.224 F4 · shares: Shares earned due to performance factor of 116.4% upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionCommon Stock | 2,903 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002357 · doc4.xml · nonDerivative · entry 3 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,405.224 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Kapusta Ronald AController, CAO
|
GrantRestricted Share Units · Derivative | 1,414 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002358 · doc4.xml · derivative · entry 11 Kapusta Ronald A · CIK 0001654212 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,414 Underlying: Common Stock · 1,414 shares Expires not disclosed F9 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F9 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Kapusta Ronald AController, CAO
|
Exercise / conversionPerformance Share Units · Derivative | 2,839 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002358 · doc4.xml · derivative · entry 10 Kapusta Ronald A · CIK 0001654212 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,839 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. F3 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Kapusta Ronald AController, CAO
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 6,880 | $0.00 Strike: $131.94 | $0.00 |
DisclosureSEC source: 0001225208-19-002358 · doc4.xml · derivative · entry 9 Kapusta Ronald A · CIK 0001654212 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,880 Underlying: Common Stock · 6,880 shares Expires 2029-02-12 F8 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Kapusta Ronald AController, CAO
|
Tax withholdingCommon Stock | 940 | $131.94 | $124,023.60 |
DisclosureSEC source: 0001225208-19-002358 · doc4.xml · nonDerivative · entry 5 Kapusta Ronald A · CIK 0001654212 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,757 F5 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Kapusta Ronald AController, CAO
|
GrantCommon Stock | 466 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002358 · doc4.xml · nonDerivative · entry 4 Kapusta Ronald A · CIK 0001654212 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,697 F4 · shares: Shares earned due to performance factor of 116.4% upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC |
Kapusta Ronald AController, CAO
|
Exercise / conversionCommon Stock | 2,839 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002358 · doc4.xml · nonDerivative · entry 3 Kapusta Ronald A · CIK 0001654212 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,231 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 02:14 UTC |
Duato JoaquinVice Chair, Exec Committee
|
Exercise / conversionRestricted Share Units · Derivative | 9,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002347 · doc4.xml · derivative · entry 7 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,049 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 02:14 UTC |
Duato JoaquinVice Chair, Exec Committee
|
Tax withholdingCommon Stock | 2,798 | $132.00 | $369,336.00 |
DisclosureSEC source: 0001225208-19-002347 · doc4.xml · nonDerivative · entry 2 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,806 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 02:14 UTC |
Duato JoaquinVice Chair, Exec Committee
|
Exercise / conversionCommon Stock | 9,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002347 · doc4.xml · nonDerivative · entry 1 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,604 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 02:14 UTC |
Gorsky AlexDirector · Chairman, CEO
|
Exercise / conversionRestricted Share Units · Derivative | 29,579 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002348 · doc4.xml · derivative · entry 10 Gorsky Alex · CIK 0001453149 · Director · Chairman, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,579 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting. F2 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 02:14 UTC |
Gorsky AlexDirector · Chairman, CEO
|
Tax withholdingCommon Stock | 11,708 | $132.00 | $1,545,456.00 |
DisclosureSEC source: 0001225208-19-002348 · doc4.xml · nonDerivative · entry 4 Gorsky Alex · CIK 0001453149 · Director · Chairman, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,756 F3 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 02:14 UTC |
Gorsky AlexDirector · Chairman, CEO
|
Exercise / conversionCommon Stock | 29,579 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002348 · doc4.xml · nonDerivative · entry 3 Gorsky Alex · CIK 0001453149 · Director · Chairman, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352,464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 02:14 UTC |
McEvoy AshleyEVP, WW Chair, Medical Devices
|
Exercise / conversionRestricted Share Units · Derivative | 6,599 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002349 · doc4.xml · derivative · entry 8 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,599 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 8, 2016, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. F8 · derivative.expiration_date: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 8, 2016, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 02:14 UTC |
McEvoy AshleyEVP, WW Chair, Medical Devices
|
Tax withholdingCommon Stock | 1,824 | $132.00 | $240,768.00 |
DisclosureSEC source: 0001225208-19-002349 · doc4.xml · nonDerivative · entry 2 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,268.4243 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 02:14 UTC |
McEvoy AshleyEVP, WW Chair, Medical Devices
|
Exercise / conversionCommon Stock | 6,599 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002349 · doc4.xml · nonDerivative · entry 1 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,092.4243 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 02:14 UTC |
Mesquita Jorge S.Exec VP, WW Chair, Consumer
|
Exercise / conversionRestricted Share Units · Derivative | 6,787 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002350 · doc4.xml · derivative · entry 6 Mesquita Jorge S. · CIK 0001547344 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,787 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 02:14 UTC |
Mesquita Jorge S.Exec VP, WW Chair, Consumer
|
Tax withholdingCommon Stock | 3,009 | $132.00 | $397,188.00 |
DisclosureSEC source: 0001225208-19-002350 · doc4.xml · nonDerivative · entry 2 Mesquita Jorge S. · CIK 0001547344 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,170 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.